Abbott

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Abbott 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About ABT

Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. It operates through the following segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. 

CEO
Robert B. Ford
CEORobert B. Ford
Employees
115,000
Employees115,000
Headquarters
Abbott Park, Illinois
HeadquartersAbbott Park, Illinois
Founded
1888
Founded1888
Employees
115,000
Employees115,000

ABT Key Statistics

Market cap
157.85B
Market cap157.85B
Price-Earnings ratio
25.44
Price-Earnings ratio25.44
Dividend yield
2.63%
Dividend yield2.63%
Average volume
13.74M
Average volume13.74M
High today
$91.75
High today$91.75
Low today
$90.29
Low today$90.29
Open price
$91.48
Open price$91.48
Volume
19.66M
Volume19.66M
52 Week high
$139.06
52 Week high$139.06
52 Week low
$90.29
52 Week low$90.29

Stock Snapshot

Abbott(ABT) stock is priced at $90.83, giving the company a market capitalization of 157.85B. It carries a P/E multiple of 25.44 and pays a dividend yield of 2.6%.

As of 2026-05-01, Abbott(ABT) stock has fluctuated between $90.29 and $91.75. The current price stands at $90.83, placing the stock +0.6% above today's low and -1.0% off the high.

Abbott(ABT) shares are trading with a volume of 19.66M, against a daily average of 13.74M.

In the last year, Abbott(ABT) shares hit a 52-week high of $139.06 and a 52-week low of $90.29.

In the last year, Abbott(ABT) shares hit a 52-week high of $139.06 and a 52-week low of $90.29.

ABT News

Simply Wall St 2d
Abbott’s Ultreon 3.0 AI Imaging Clearance And What It Means For Valuation

Abbott Laboratories (NYSE:ABT) received U.S. FDA clearance and CE Mark for its AI powered Ultreon 3.0 Software. Ultreon 3.0 is a next generation coronary imagi...

Abbott’s Ultreon 3.0 AI Imaging Clearance And What It Means For Valuation
TipRanks 2d
Major Insider Move Signals Growing Confidence at Abbott Laboratories

New insider activity at Abbott Laboratories ( (ABT) ) has taken place on April 28, 2026. Unlock hedge fund-level data and powerful investing tools for smarter,...

Nasdaq 2d
Tuesday 4/28 Insider Buying Report: KYN, ABT

As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money. So let's look at tw...

Tuesday 4/28 Insider Buying Report: KYN, ABT

Analyst ratings

75%

of 32 ratings
Buy
75%
Hold
25%
Sell
0%

More ABT News

Nasdaq 3d
How to Pick a Healthcare Stock That Can Weather Any Market

Key Points Abbott Laboratories is a very diversified company, which can reduce some risks. The medical products maker is a committed dividend payer, too, with...

How to Pick a Healthcare Stock That Can Weather Any Market
TipRanks 3d
Abbott receives FDA clearance and CE Mark for Ultreon imaging platform

Abbott (ABT) received FDA clearance and CE Mark for its Ultreon 3.0 Software. Ultreon 3.0 is an AI powered imaging platform that uses optical coherence tomograp...

Simply Wall St 3d
Late-Breaking AFib Data on Pulsed Field Ablation Could Be A Game Changer For Abbott

In April 2026, Abbott Laboratories reported late-breaking data from four trials in its pulsed field ablation and conduction system pacing portfolios, highlighti...

Late-Breaking AFib Data on Pulsed Field Ablation Could Be A Game Changer For Abbott
Nasdaq 3d
Abbott Laboratories Price Target Decreased by 10.05% to 102.05

The average one-year price target for Abbott Laboratories (BIT:1ABT) has been revised to €102.05 / share. This is a decrease of 10.05% from the prior estimate o...

Abbott Laboratories Price Target Decreased by 10.05% to 102.05
TipRanks 3d
Abbott Expands Board and Enhances Equity Incentive Programs

Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...

People also own

Based on the portfolios of people who own ABT. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.